FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

MicuRx Gains Fast Track for Antibiotics

[ Price : $8.95]

FDA grants MicuRx Pharmaceuticals fast track status and a qualified infectious disease product desgination for contezolid (MRX-I) ...

Draft Guide on Clinicaltrials.com Money Penalties

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Civil Money Penalties Relating to the ClinicalTrials.gov Da...

11 Observations on Zhejiang Huahai FDA-483

[ Price : $8.95]

FDA releases an FDA-483 with 11 observations from an inspection at Chinas Zhejiang Huahai Pharmaceutical Co.

3 Observations in Strides Pharma Science Inspection

[ Price : $8.95]

FDA completes a pre-approval product inspection at Indias Strides Pharma Sciences with three inspection observations.

OBI Pharma Granted Orphan Status for Leukemia Drug

[ Price : $8.95]

FDA grants OBI Pharma an orphan drug designation for OBI-3424 for treating acute lymphoblastic leukemia.

Q&A Guide on Product Identifiers

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Product Identifiers Under the Drug Supply Chain Security Ac...

Clinical Trials Penalties Guidance

[ Price : $8.95]

FDA describes its approach to seeking civil money penalties from those failing to follow ClinicalTrials.gov submission requirement...

FDA Mulls New Drug Shortage Authority: Woodcock

[ Price : $8.95]

CDER director Janet Woodcock says the agency is considering whether it has new authorities available under FDASIA it can use to ad...

Guide on Product Identifier Requirements

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Product Identifier Requirements Under the Drug Supply Chain...

Guide on Heparin Labeling and Safety Testing

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Heparin-Containing Medical Devices and Combination Products...